Home | Business News | Browse by Publication | H | HIV Treatment: ALERTS!

New drug profile: Maraviroc: it's different, it's strong, and it's almost here.

Publication: HIV Treatment: ALERTS!
Publication Date: 01-JUN-07 		Format: Online
Delivery: Immediate Online Access
Full Article Title: New drug profile: Maraviroc: it's different, it's strong, and it's almost here.(Drug overview)

Article Excerpt
What is it?

Maraviroc (or Celsentri) is an HIV medication, the first of its kind. Maraviroc doesn't block HIV directly; instead, maraviroc binds to a human protein known as CCR5. This is one of the proteins HIV uses to enter human T cells. By binding to CCR5, maraviroc keeps HIV from infecting T cells.

Who's it for?

Maraviroc, in combination with other HIV meds, is indicated for treatment-experienced adults infected with CCR5-tropic (attracted to something specified) HIV.

What does that mean?

In order for HIV to infect a T cell, the virus must first...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from HIV Treatment: ALERTS!
Fuzeon update.(Brief article), June 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.